Sanofi (SNY) Financial Statements & Analysis

Sanofi (SNY) Income Statement

Sanofi reported revenue of EUR 46.72B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 5.5% from EUR 44.29B a year earlier. Net income was EUR 7.81B, up 40.5% year over year, a net margin of 16.7%. Gross margin was 72.1% and operating margin 20.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was EUR 12.30B, up 14.6% from the same quarter a year earlier.

Sanofi Income Statement Analysis

Values in billions EUR

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Sanofi income statement - Annual data in billions EUR
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	46.72	44.29	41.62	40.56	39.18	37.37	37.63	35.68	36.22
Cost of Revenue	13.05	13.21	12.63	11.88	12.26	12.16	11.98	11.44	11.61
Gross Profit	33.67	31.08	28.99	28.68	26.92	25.21	25.65	24.24	24.61
Operating Expenses
Research & Development	7.84	7.39	6.51	6.50	5.69	5.53	6.02	5.89	5.47
Selling, General & Administrative	10.24	9.82	8.93	8.74	9.56	9.39	9.88	9.86	10.07
Operating Expenses	24.07	22.16	22.03	17.75	18.79	11.10	22.60	19.57	18.80
Operating Income	9.60	8.92	6.96	10.93	8.13	14.11	3.05	4.68	5.80
Other Income/Expense
Interest Income	0.33	0.44	0.53	0.24	0.00	0.03	0.09	0.07	0.05
Interest Expense	0.63	0.70	0.51	0.47	0.38	0.43	0.54	0.49	0.33
Other Income/Expense	-3.58	-1.74	-0.85	-0.77	-0.29	0.02	-0.04	0.23	-0.19
Income
Income Before Tax	6.02	6.70	6.12	9.94	7.84	14.14	3.01	4.90	5.62
Income Tax Expense	1.04	1.20	1.02	1.91	1.56	1.81	0.12	0.48	1.72
Net Income	7.81	5.56	5.40	8.37	6.22	12.29	2.75	4.31	8.42
Net Income - Continuous Operations	7.81	5.55	5.40	8.08	6.22	12.29	2.75	4.31	8.42
Net Income - Discontinued Operations	2.87	0.06	0.34	0.40	-	-	-	-	-
EBITDA	12.48	10.99	11.39	13.51	11.54	17.88	10.66	9.18	9.64
EBIT	9.65	7.40	6.89	10.40	8.57	-	-	-	-
Depreciation & Amortization	5.68	1.75	4.43	1.80	3.35	3.67	7.45	4.28	3.69
Earnings Per Share
Basic EPS	3.00	2.00	2.00	3.00	2.00	5.00	1.00	2.00	2.00
Diluted EPS	3.00	2.00	2.00	3.00	2.00	5.00	1.00	2.00	3.00
Basic Shares Outstanding	2.44	2.50	2.50	2.50	2.51	2.51	2.50	2.49	2.51
Diluted Shares Outstanding	2.44	2.50	2.51	2.50	2.51	2.51	2.50	2.49	2.51

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sanofi Financial Statements

What was Sanofi's revenue in fiscal 2025?

Sanofi reported revenue of EUR 46.72B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 5.5% from EUR 44.29B a year earlier.

Is Sanofi profitable?

Yes. Sanofi earned net income of EUR 7.81B in fiscal 2025, a net margin of 16.7%. In fiscal 2024 it earned EUR 5.56B.

What is Sanofi's operating margin?

Sanofi's operating income was EUR 9.60B on revenue of EUR 46.72B in fiscal 2025, an operating margin of 20.5%, compared with 20.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition